Semaglutide
Semaglutide (Research-Grade)
Semaglutide is a GLP-1 receptor agonist peptide widely studied for metabolic research. It mimics incretin hormones to regulate appetite, insulin secretion, and glucose metabolism. This is the pure research-grade compound for scientific investigation.
分子データ
純度
4113.58 g/mol
分子量
SGL-2026-0501
バッチ番号
HPLC + Mass Spectrometry
テスト方法
純度検証済み
ラボテスト済み
Modified GLP-1(7-37) analog with C-18 fatty acid chain
研究論文
ラボ認証
スキャンして検証
バッチ番号: SGL-2026-0501
純度: 99.1%
効果プロファイル
主なメリット
相性の良い組み合わせ
これらのペプチドは、より良い結果のためにSemaglutideとよく組み合わせられます。
関連ペプチド
Semamax
Semaglutide
Semaglutide is a long-acting GLP-1 receptor agonist originally developed for the treatment of type 2 diabetes. It mimics the action of human GLP-1 to regulate blood sugar, insulin secretion, and appetite. Semaglutide has gained widespread use for weight management.
L-Carnitine
Injectable L-Carnitine
L-Carnitine is a naturally occurring compound that helps transport fatty acids into the mitochondria for energy production. Injectable forms bypass digestion, offering higher bioavailability and faster effects. Commonly used to support fat loss, energy, and athletic performance.